You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB0448 Baseline Characteristics and Changes in Disease Activity at 12 Months in Patients Treated with Abatacept Versus Other Biologic Disease-Modifying Antirheumatic Drugs in Clinical Practice Setting – Results from the Brass Registry

Alerts

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - other biologic treatment
AB0448 Baseline Characteristics and Changes in Disease Activity at 12 Months in Patients Treated with Abatacept Versus Other Biologic Disease-Modifying Antirheumatic Drugs in Clinical Practice Setting – Results from the Brass Registry
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address